Why Am I Not Losing Weight on Semaglutide?

If you have been on semaglutide for more than eight weeks without meaningful progress, that is a reasonable time to check in with your provider. Before then, your dose may still be subtherapeutic. Most people do not see significant weight loss until they reach 1 mg or higher, which can take two months or more with proper titration. A stall at eight-plus weeks warrants a clinical conversation about dose adjustment, protocol refinement, or ruling out other factors.

Yes, but the most common reason is water retention masking fat loss. Hormonal shifts, sodium intake, new exercise routines, and stress all cause temporary water weight that can hide several pounds of real fat loss. This is why tracking measurements and how clothes fit is just as important as the scale. If you are confident you are in a deficit and still not seeing movement after three to four weeks, check your tracking accuracy and discuss with your provider.

Semaglutide does not stop working, but your body does adapt. This is the plateau effect, and it happens with virtually every weight loss intervention. The medication is still active, but your metabolism adjusts to your new, lower body weight. At this point, the right clinical adjustment — a dose increase, a short diet break, or a change in your exercise routine — can restart progress. Stopping the medication entirely is rarely the right answer.

Very normal. The first few weeks often produce rapid results as your body sheds water weight and adjusts to reduced calorie intake. After that initial drop, weight loss typically slows to a more gradual pace of 1 to 2 pounds per week. A stall after months at the same dose is also common and is one of the most discussed topics in GLP-1 clinical support. It is almost never a reason to stop — it is a reason to adjust.

Not without speaking to your provider. Dose increases should follow a structured titration schedule, not be driven by short-term scale frustration. Jumping doses too quickly increases the risk of severe nausea and other GI side effects without necessarily accelerating results. That said, staying at a subtherapeutic dose indefinitely is also counterproductive. This is exactly the kind of decision clinical support is meant to guide.

Stress alone will not fully block semaglutide, but it can absolutely slow your progress. Elevated cortisol increases appetite, promotes abdominal fat storage, and drives water retention. Combined with semaglutide's already-suppressed appetite, the result can be a frustrating stall — you are eating less but your body is holding on. Managing stress through sleep, movement, and support is not optional; it directly impacts your results.